Search

everythinglearnresearchcommunity

for

Search:↓

Gene variation affects prostate issues and hair loss.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Men with testicular cancer were less likely to experience baldness and severe acne.

Mutations in certain receptors can cause diseases and offer new treatment options.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Androgens increase cervical cancer risk and affect its development.

A new compound was made that might help treat diseases related to male hormones.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.